Generics News

Generics News

ANI Launches Generic Rythmol Tablets

ANI Pharmaceuticals announced the availability of Propafenone HCl Tablets, the generic version of GlaxoSmithKline's Rythmol.

Teva Launches Generic Exforge

Teva announced the launch of Amlodipine and Valsartan Tablets, the generic version of Novartis' Exforge.

New Fentanyl Dosage Strengths Launched By Mylan

Mylan announced the launch of Fentanyl Transdermal System 37.5mcg/hr, 62.5mcg/hr, and 87.5mcg/hr, three new intermediate dosage strengths.

Mylan Launches Generic Antabuse

Mylan announced the launch of Disulfiram Tablets, the generic version of Odyssey's Antabuse.

Mylan Launches Generic Subutex

Mylan announced the launch of Buprenorphine HCl Sublingual Tablets, the generic version of Reckitt Benckiser's Subutex.

Etodolac Capsules Launched by ANI

ANI Pharmaceuticals announced the launch of Etodolac 200mg Capsules, formerly known under the brand name Lodine.

Generic Temovate Launched by Actavis

Actavis announced the launch of Clobetasol Propionate Cream 0.05%, the generic version of Fougera's Temovate.

Generic Seasonique Now Available

The Food and Drug Administration (FDA) has approved Ashlyna (levonorgestrel/ethinyl estradiol and ethinyl estradiol; Glenmark Generics) Extended-Cycle Oral Contraceptive Tablets, the generic version of Teva Women's Health's Seasonique.

Actavis Approved for Generic Subutex

Actavis announced that it has received final approval from the FDA for Buprenorphine Sublingual Tablets, the generic version of Reckitt Benckiser's Subutex.

Teva Launches Generic Nexium

Teva announced the launch of Esomeprazole Magnesium Delayed-Release Capsules, the generic version of AstraZeneca's Nexium.